|
|
| All participants (N = 1552) | Received products other than FACILLE (N = 508) |
| Injection volume (ml)a | n | 1475 |
|
| Mean (SD) | 1.39 (0.658) |
| |
| Median | 1.00 |
| |
| Minimum | 0.4 |
| |
| Maximum | 6.0 |
| |
| Unknown | n (%) | 77 (5.0) |
|
| ≤1 | n (%) | 952 (61.3) |
|
| 1 - ≤2 | n (%) | 451 (29.1) |
|
| >2 | n (%) | 72 (4.6) |
|
| Injection timesb | n | 1277 |
|
| Mean (SD) | 2.4 (1.68) |
| |
| Median | 2.0 |
| |
| Minimum | 1 |
| |
| Maximum | 12 |
| |
| Unknown | n (%) | 275 (17.7) |
|
| 1 | n (%) | 541 (34.9) |
|
| 2 | n (%) | 277 (17.8) |
|
| 3 or more | n (%) | 459 (29.6) |
|
| Injection Summary |
|
|
|
| History injections | n (%) |
| 165 (32.5) |
| Injection day of FACILLE | n (%) | 1552 (100.0) | 270 (53.1) |
| 2 weeks post-injection | n (%) | 10 (0.6) | 14 (2.8) |
| 1 month post-injection | n (%) | 3 (0.2) | 3 (0.6) |
| 3 months post-injection | n (%) | 9 (0.6) | 30 (5.9) |
| 6 months post-injection | n (%) | 21 (1.4) | 63 (12.4) |
| 9 months post-injection | n (%) | 20 (1.3) | 64 (12.6) |
| 12 months post-injection | n (%) | 21 (1.4) | 47 (9.3) |
| 18 months post-injection | n (%) | 10 (0.6) | 32 (6.3) |
| 24 months post-injection | n (%) | 3 (0.2) | 40 (7.9) |
| 30 months post-injection | n (%) | 0 | 34 (6.7) |
| 36 months post-injection | n (%) | 4 (0.3) | 12 (2.4) |